HopeStage
Back to all studies
RecruitingNCT06017622

THC levels in children treated in emergency departments for cannabis-related reduced alertness

About this titleRead the official source — NCT06017622
Observational studyUnited StatesDepression
The study in practice

Understand this study

Listed locations
Worcester and 2 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 1, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
36
Sponsor
Anebulo Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
Not clearly listed
Official registry ID
NCT06017622
Official title
Show the full official title

Multi-center Observational Study of Plasma Concentrations of THC and Its Metabolites in Pediatric Patients Visiting Emergency Departments for Acute Cannabis-induced CNS Depression

Recruitment & locations

Currently recruiting

Worcester · Cincinnati · Portland

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Anebulo Pharmaceuticals.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies